pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

Sen. Bill Cassidy’s impeachment vote and RFK Jr. confirmation jeopardize his political future

May 13, 2026·read at STAT ↗Negative

Sen. Bill Cassidy, a former physician turned lawmaker, has taken political actions that threaten his standing in Louisiana. He voted to impeach former President Donald Trump and supported the confirmation of RFK Jr., moves that have alienated many of his MAGA‑aligned constituents.

These decisions appear to have cost him support among the party’s base, and he has yet to secure backing from the broader MAHA electorate. Observers note that his reputation for evidence‑based policy and health‑care expertise has not insulated him from the fallout.

Both supporters and critics in Louisiana view Cassidy’s career as being at a crossroads, with his long‑standing health‑care credentials contrasted against the political risks he has taken.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career”

read at STAT ↗
805 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
FATE THERAPEUTICS INCLEADING

related stories

  • Jul 28STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDSTAT
  • Jul 27Sarepta names former AbbVie R&D exec Michael Severino as next CEOBioSpace
  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • May 12Supreme Court extends mifepristone deadlineSTAT
  • May 4Opinion: Are blue zones real? Answering that question is harder than everSTAT